CID 9828617

Sb-414796

Structural Information

Molecular Formula
C29H36N4O4S
SMILES
CC1=NC(=NO1)C2=CC(=CC=C2)C(=O)NC3CCC(CC3)CCN4CCC5=C(CC4)C=C(C=C5)S(=O)(=O)C
InChI
InChI=1S/C29H36N4O4S/c1-20-30-28(32-37-20)24-4-3-5-25(18-24)29(34)31-26-9-6-21(7-10-26)12-15-33-16-13-22-8-11-27(38(2,35)36)19-23(22)14-17-33/h3-5,8,11,18-19,21,26H,6-7,9-10,12-17H2,1-2H3,(H,31,34)
InChIKey
ZHQUFEJLPBTKSM-UHFFFAOYSA-N
Compound name
3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[4-[2-(7-methylsulfonyl-1,2,4,5-tetrahydro-3-benzazepin-3-yl)ethyl]cyclohexyl]benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

4
References

1
Patents

536.2457 Da
Monoisotopic Mass

4.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 537.25298 235.6
[M+Na]+ 559.23492 244.5
[M+NH4]+ 554.27952 239.5
[M+K]+ 575.20886 239.1
[M-H]- 535.23842 241.2
[M+Na-2H]- 557.22037 239.6
[M]+ 536.24515 238.8
[M]- 536.24625 238.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe